NDN and leukemia: While Necdin null leukemia cells expressing AML1-ETO9a show enhanced apoptosis at 48 hours after high concentration of AraC treatment (Figure 6E), these cells had decreased apoptosis at 72 hours after AraC treatment (Figure 6G).